I agree that this site is using cookies. You can find further informations here.
X
Bladé, Joan
472  results:
Search for persons X
?
1

A Simple Frailty Score Predicts Survival and Early Mortalit..:

Ríos-Tamayo, Rafael ; Lecumberri, Ramón ; Cibeira, María Teresa...
Cancers.  16 (2024)  9 - p. 1689 , 2024
Link: https://doi.org/10.3390/..
 
?
2

The evolving pattern of the monoclonal protein improves the..:

de Daniel, Anna ; Rodríguez‐Lobato, Luis Gerardo ; Tovar, Natalia...
HemaSphere.  8 (2024)  5 - p. , 2024
Link: https://doi.org/10.1002/..
 
?
3

Selinexor, daratumumab, bortezomib and dexamethasone for th..:

González-Calle, Verónica ; Rodríguez-Otero, Paula ; Sureda, Anna...
Haematologica.  , 2024
Link: https://doi.org/10.3324/..
 
?
4

A case of benign immunoglobulin D monoclonal gammopathy of ..:

Anderson Jr., Larry D. ; Bladé, Joan ; Kyle, Robert A.
eJHaem.  5 (2024)  1 - p. 235-237 , 2024
Link: https://doi.org/10.1002/..
 
?
5

P-367 High-risk cytogenetic abnormalities in multiple myelo..:

Rodriguez-Otero, Paula ; Gonzalez-Calle, Veronica ; Calasanz, Maria-Jose...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S241-S242 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Outcomes of Patients with Newly Diagnosed Transplant-Inelig..:

Rodríguez-Lobato, Luis Gerardo ; Tovar, Natalia ; de Daniel, Anna...
Cancers.  15 (2023)  21 - p. 5261 , 2023
Link: https://doi.org/10.3390/..
 
?
7

Recovery of uninvolved heavy/light chain pair immunoparesis..:

Lakhwani, Sunil ; Rosiñol, Laura ; Puig, Noemí...
Haematologica.  , 2023
Link: https://doi.org/10.3324/..
 
?
8

OA-12 Predictors of unsustained measurable residual disease..:

Guerrero, Camila ; Puig, Noemi ; Cedena, Teresa...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S7-S8 , 2023
Link: https://doi.org/10.1016/..
 
?
9

P878: SELINEXOR IN COMBINATION WITH DARATUMUMAB-BORTEZOMIB ..:

Gonzalez-Calle, Veronica ; Rodríguez-Otero, Paula ; Sureda, Anna...
HemaSphere.  7 (2023)  S3 - p. e954902c , 2023
Link: https://doi.org/10.1097/..
 
?
10

P-311 Survival of patients with relapsed/refractory multipl..:

Rosinol, Laura ; de Larrea, Carlos Fernández ; Cibeira, Maria Teresa...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S209-S210 , 2023
Link: https://doi.org/10.1016/..
 
?
11

Clinical perspectives on the optimal use of lenalidomide pl..:

Richardson, Paul G. ; Durie, Brian G. ; Rosiñol, Laura...
Haematologica.  108 (2023)  11 - p. 2894-2912 , 2023
Link: https://doi.org/10.3324/..
 
?
12

P-045 Early treatment with bispecific T-cell redirectors (t..:

Rodriguez-Otero, Paula ; Mateos, Maria-Victoria ; Palacios, Juan José Lahuerta...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S59-S60 , 2023
Link: https://doi.org/10.1016/..
 
?
13

Randomized phase II study of weekly carfilzomib 70 mg/m2 an..:

Puertas, Borja ; González-Calle, Verónica ; Sureda, Anna...
Haematologica.  , 2023
Link: https://doi.org/10.3324/..
 
?
14

Management of multiple myeloma-related renal impairment: re..:

Dimopoulos, Meletios A ; Merlini, Giampaolo ; Bridoux, Frank...
The Lancet Oncology.  24 (2023)  7 - p. e293-e311 , 2023
Link: https://doi.org/10.1016/..
 
?
15

OA-20 Genomic profiling of high-risk smoldering myeloma pat..:

Medina, Alejandro ; Vázquez, Iria ; Cuenca, Isabel...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S12-S13 , 2023
Link: https://doi.org/10.1016/..
 
1-15